*** Proof of Product ***
Exploring the Essential Features of “Wall Street Prep – Biotech Sum of the Parts Valuation”
About Course:
What You Will Learn
- Market size and model potential revenue for a therapeutic asset in clinical development
- Road-map the path to commercialization for a biotech through the FDA approval process
- Apply the appropriate “probability of success”” to a clinical-stage pre-revenue biotech company
- Apply key assumptions and tie together a long-range forecast of multiple products with a DCF analysis
Biotech Sum of the Parts Valuation
- Biotech SOTP welcome
- Biotech SOTP introduction
- Course Downloads
- Overview of a sum of the parts valuation
- Major building blocks for a biotech SOTP
- Model assumptions dashboard
- Biotech company lifecycle
- Identify peak revenue opportunity
- Therapeutic areas overview
- Product launch timing and uptake curve
- Patent life and loss of exclusivity
- Road to commercialization
- FDA clinical trials
- Building a commercial infrastructure
- Completing the SOTP
- Probability of success
- Build out one part of the SOTP (Product #1)
- Finalizing the valuation model
- Valuation sensitivities
- Example: Blueprint Medicines Corp
- Biotech SOTP Course Review
Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/
